Mouse and human embryonic stem cells: Can they improve human health by preventing disease?

Current Topics in Medicinal Chemistry

Volumn 11, Issue 13, 2011, Pages 1638-1652

  Talbot, Prue ^a   Lin, Sabrina ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cigarette smoke; Drug testing; Embryonic stem cell test; Embryonic stem cells; Harm reduction cigarettes; In vitro assays; Predictive toxicology; Toxicological testing

Indexed keywords

ARSENIC; CIGARETTE SMOKE; DICHROMATE POTASSIUM; FLUOROURACIL; FLUOXETINE; HYDROXYUREA; LITHIUM; MITOMYCIN; NICOTINE; OCTAMER TRANSCRIPTION FACTOR 4; PARAQUAT; RETINOIC ACID; SELENOPROTEIN; TRANSCRIPTION FACTOR GATA 4; VALPROIC ACID;

CELL MATURATION; CYTOTOXICITY; EMBRYOID BODY; EMBRYONIC STEM CELL; EMBRYOTOXICITY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIFE CYCLE; NONHUMAN; PREDICTION; PRENATAL DEVELOPMENT; PRENATAL EXPOSURE; REVIEW;

ANIMALS; EMBRYONIC STEM CELLS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL HEALTH; HUMANS; MICE; TOXICITY TESTS;

EID: 79960020273     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/156802611796117621     Document Type: Review

References (92)

1. Lloyd-Smith, M.; Sheffield-Brotherton, B. Children's environmental health: intergenerational equity in action--a civil society perspective. Ann. N Y. Acad. Sci., 2008, 1140, 190-200.
2. Grandjean, P.; Bellinger, D.; Bergman, A.; Cordier, S.; Davey-Smith, G.; Eskenazi, B.; Gee, D.; Gray, K.; Hanson, M.; van den Hazel, P.; Heindel, J.J.; Heinzow, B.; Hertz-Picciotto, I.; Hu, H.; Huang, T.T.; Jensen, T.K.; Landrigan, P.J.; McMillen, I.C.; Murata, K.; Ritz, B.; Schoeters, G.; Skakkebaek, N.E.; Skerfving, S.; Weihe, P. The Faroes statement: human health effects of developmental exposure to chemicals in our environment. Basic Clin. Pharmacol. Toxicol., 2007, 102, 73-75.
3. Chapin, R.; Augustine-Rauch, K.; Beyer, B.; Daston, G.; Finnell, R.; Flynn, T.; Hunter, S.; Mirkes, P.; O'Shea, K.S.; Piersma, A.; Sandler, D.; Vanparys, P.; Van Maele-Fabry, G. State of the art in developmental toxicity screening methods and a way forward: a meeting report addressing embryonic stem cells, whole embryo culture, and zebrafish. Birth Defects Res. B. Dev. Reprod Toxicol., 2008, 83 (4), 446-456.
4. Chapin, R.; Stedman, D.; Paquette, J.; Streck, R.; Kumpf, S.; Deng, S. Struggles for equivalence: in vitro developmental toxicity model evolution in pharmaceuticals in 2006. Toxicol. In vitro 2007, 21 (8), 1545-1551.
5. McNeish, J. Embryonic stem cells in drug discovery. Nat. Rev. Drug Discov., 2004, 3 (1), 70-80
6. Piersma, A.H. Validation of alternative methods for developmental toxicity testing. Toxicol. Lett., 2004, 149 (1-3), 147-153.
7. Evans, M.J.; Kaufman, M.H. Establishment in culture of pluripotential cells from mouse embryos. Nature, 1981, 292 (5819), 154-156.
8. Martin, G.R., Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA, 1981, 78 (12), 7634-7638.
9. Gorba, T.; Allsopp, T.E. Pharmacological potential of embryonic stem cells. Pharmacol. Res., 2003, 47 (4), 269-278.
10. Thomson, J.A.; Itskovitz-Eldor, J.; Shapiro, S.S.; Waknitz, M.A.; Swiergiel, J.J.; Marshall, V.S.; Jones, J.M. Embryonic stem cell lines derived from human blastocysts. Science, 1998, 282 (5391), 1145-1147.
11. Smith, K.P.; Luong, M.X.; Stein, G.S. Pluripotency: toward a gold standard for human ES and iPS cells. J. Cell Physiol., 2009, 220 (1), 21-29
12. Stahlberg, A.; Bengtsson, M.; Hemberg, M.; Semb, H. Quantitative transcription factor analysis of undifferentiated single human embryonic stem cells. Clin. Chem., 2009, 55(12),2162-2170
13. Ohnuki, M.; Takahashi, K.; Yamanaka, S. Generation and characterization of human induced pluripotent stem cells. Curr. Protoc. Stem Cell Biol., 2009, Chapter 4, Unit 4A 2
14. Okita, K.; Ichisaka, T.; Yamanaka, S. Generation of germline-competent induced pluripotent stem cells. Nature, 2007, 448 (7151), 313-317.
15. Amabile, G.; Meissner, A. Induced pluripotent stem cells: current progress and potential for regenerative medicine. Trends Mol. Med., 2009, 15 (2), 59-68.
16. Genschow, E.; Spielmann, H.; Scholz, G.; Pohl, I.; Seiler, A.; Clemann, N.; Bremer, S.; Becker, K. Validation of the embryonic stem cell test in the international ECVAM validation study on three in vitro embryotoxicity tests. Altern Lab. Anim., 2004, 32 (3), 209-244.
17. Spielmann, H.; Liebsch, M. Validation successes: chemicals. Altern. Lab. Anim., 2002, 30 (Suppl 2), 33-40.
18. Bremer, S.; Hartung, T. The use of embryonic stem cells for regulatory developmental toxicity testing in vitro--the current status of test development. Curr. Pharm. Des., 2004, 10 (22), 2733-2747.
19. Hartung, T.; Bremer, S.; Casati, S.; Coecke, S.; Corvi, R.; Fortaner, S.; Gribaldo, L.; Halder, M.; Hoffmann, S.; Roi, A.J.; Prieto, P.; Sabbioni, E.; Scott, L.; Worth, A.; Zuang, V. A modular approach to the ECVAM principles on test validity. Altern. Lab. Anim., 2004, 32 (5), 467-472.
20. De Smedt, A.; Steemans, M.; De Boeck, M.; Peters, A.K.; van der Leede, B.J.; Van Goethem, F.; Lampo, A.; Vanparys, P. Optimisation of the cell cultivation methods in the embryonic stem cell test results in an increased differentiation potential of the cells into strong beating myocard cells. Toxicol. Vitro, 2008, 22 (7), 1789-1796.
21. Peters, A.K.; Wouwer, G.V.; Weyn, B.; Verheyen, G.R.; Vanparys, P.; Gompel, J.V. Automated analysis of contractility in the embryonic stem cell test, a novel approach to assess embryotoxicity. Toxicol. In Vitro, 2008, 22 (8), 1948-1956.
22. Paquette, J.A.; Kumpf, S.W.; Streck, R.D.; Thomson, J.J.; Chapin, R.E.; Stedman, D.B. Assessment of the embryonic stem cell test and application and use in the pharmaceutical industry. Birth Defects. Res. B Dev. Reprod. Toxicol., 2008, 83 (2), 104-111.
23. Seiler, A.; Visan, A.; Buesen, R.; Genschow, E.; Spielmann, H. Improvement of an in vitro stem cell assay for developmental toxicity: the use of molecular endpoints in the embryonic stem cell test. Reprod. Toxicol., 2004, 18 (2), 231-240.
24. Buesen, R.; Genschow, E.; Slawik, B.; Visan, A.; Spielmann, H.; Luch, A.; Seiler, A. Embryonic stem cell test remastered: comparison between the validated est and the new molecular facs est for assessing developmental toxicity in vitro. Toxicol Sci 2009, 108 (2), 389-400.
25. van Dartel, D.A.; Pennings, J.L.; Hendriksen, P.J.; van Schooten, F.J.; Piersma, A.H. Early gene expression changes during embryonic stem cell differentiation into cardiomyocytes and their modulation by monobutyl phthalate. Reprod. Toxicol., 2009, 27 (2), 93-102.
26. Pellizzer, C.; Bello, E.; Adler, S.; Hartung, T.; Bremer, S. Detection of tissue-specific effects by methotrexate on differentiating mouse embryonic stem cells. Birth Defects Res. B Dev. Reprod. Toxicol., 2004, 71 (5), 331-341.
27. zur Nieden, N.I.; Kempka, G.; Ahr, H.J. Molecular multiple endpoint embryonic stem cell test--a possible approach to test for the teratogenic potential of compounds. Toxicol. Appl. Pharmacol., 2004, 194 (3), 257-269.
28. van Dartel, D.A.; Zeijen, N.J.; de la Fonteyne, L.J.; van Schooten, F.J.; Piersma, A.H. Disentangling cellular proliferation and differentiation in the embryonic stem cell test, and its impact on the experimental protocol. Reprod. Toxicol., 2009, 28 (2), 254-261.
29. Peters, A.K.; Steemans, M.; Hansen, E.; Mesens, N.; Verheyen, G.R.; Vanparys, P. Evaluation of the embryotoxic potency of compounds in a newly revised high throughput embryonic stem cell test. Toxicol. Sci., 2008, 105 (2), 342-350.
30. Festag, M.; Sehner, C.; Steinberg, P.; Viertel, B. An in vitro embryotoxicity assay based on the disturbance of the differentiation of murine embryonic stem cells into endothelial cells. I: Establishment of the differentiation protocol. Toxicol. In Vitro, 2007, 21 (8), 1619-1630.
31. Festag, M.; Viertel, B.; Steinberg, P.; Sehner, C. An in vitro embryotoxicity assay based on the disturbance of the differentiation of murine embryonic stem cells into endothelial cells. II. Testing of compounds. Toxicol. In Vitro, 2007, 21 (8), 1631-1640.
32. Verwei, M.; van Burgsteden, J.A.; Krul, C.A.; van de Sandt, J.J.; Freidig, A.P. Prediction of in vivo embryotoxic effect levels with a combination of in vitro studies and PBPK modelling. Toxicol. Lett., 2006, 165 (1), 79-87.
33. Adler, S.; Pellizzer, C.; Paparella, M.; Hartung, T.; Bremer, S. The effects of solvents on embryonic stem cell differentiation. Toxicol. In Vitro, 2006, 20 (3), 265-271.
34. de Jong, E.; Louisse, J.; Verwei, M.; Blaauboer, B.J.; van de Sandt, J.J.; Woutersen, R.A.; Rietjens, I.M.; Piersma, A.H. Relative developmental toxicity of glycol ether alkoxy acid metabolites in the embryonic stem cell test as compared with the in vivo potency of their parent compounds. Toxicol. Sci., 2009, 110 (1), 117-124.
35. Kusakawa, S.; Yamauchi, J.; Miyamoto, Y.; Sanbe, A.; Tanoue, A. Estimation of embryotoxic effect of fluoxetine using embryonic stem cell differentiation system. Life Sci., 2008, 83 (25-26), 871-877.
36. Stummann, T.C.; Hareng, L.; Bremer, S. Embryotoxicity hazard assessment of cadmium and arsenic compounds using embryonic stem cells. Toxicology, 2008, 252 (1-3), 118-122.
37. Imai, K.; Nakamura, M. In vitro embryotoxicity testing of metals for dental use by differentiation of embryonic stem cell test. Congenit Anom, (Kyoto) 2006, 46 (1), 34-38.
38. Ariza, M.E.; Williams, M.V. Lead and mercury mutagenesis: type of mutation dependent upon metal concentration. J. Biochem. Mol. Toxicol., 1999, 13 (2), 107-112.
39. Luo, H.; Lu, Y.; Shi, X.; Mao, Y.; Dalal, N.S. Chromium (IV)-mediated fenton-like reaction causes DNA damage: implication to genotoxicity of chromate. Ann. Clin. Lab. Sci., 1996, 26 (2), 185-191.
40. Huang, Z.; Li, J.; Zhang, S.; Zhang, X. Inorganic arsenic modulates the expression of selenoproteins in mouse embryonic stem cell. Toxicol. Lett., 2009, 187 (2), 69-76.
41. Chen, L.; Ovesen, J.L.; Puga, A.; Xia, Y. Distinct contributions of JNK and p38 to chromium cytotoxicity and inhibition of murine embryonic stem cell differentiation. Environ. Health Perspect., 2009, 117 (7), 1124-1130.
42. Schwengberg, S.; Bohlen, H.; Kleinsasser, N.; Kehe, K.; Seiss, M.; Walther, U.I.; Hickel, R.; Reichl, F.X. In vitro embryotoxicity assessment with dental restorative materials. J. Dent., 2005, 33 (1), 49-55.
43. Perla, V.; Perrin, N.A.; Greenlee, A.R. Paraquat toxicity in a mouse embryonic stem cell model. Toxicol. In Vitro, 2008, 22 (2), 515-524.
44. Na, L.; Wartenberg, M.; Nau, H.; Hescheler, J.; Sauer, H. Anticonvulsant valproic acid inhibits cardiomyocyte differentiation of embryonic stem cells by increasing intracellular levels of reactive oxygen species. Birth Defects Res. A Clin. Mol. Teratol., 2003, 67 (3), 174-180.
45. Murabe, M.; Yamauchi, J.; Fujiwara, Y.; Miyamoto, Y.; Hiroyama, M.; Sanbe, A.; Tanoue, A. Estimation of the embryotoxic effect of CBZ using an ES cell differentiation system. Biochem. Biophys. Res. Commun., 2007, 356 (3), 739-744.
46. Murabe, M.; Yamauchi, J.; Fujiwara, Y.; Hiroyama, M.; Sanbe, A.; Tanoue, A. A novel embryotoxic estimation method of VPA using ES cells differentiation system. Biochem. Biophys. Res. Commun., 2007, 352 (1), 164-169.
47. Rolletschek, A.; Blyszczuk, P.; Wobus, A.M. Embryonic stem cellderived cardiac, neuronal and pancreatic cells as model systems to study toxicological effects. Toxicol. Lett., 2004, 149 (1-3), 361-369.
48. Stummann, T.C.; Hareng, L.; Bremer, S. Embryotoxicity hazard assessment of methylmercury and chromium using embryonic stem cells. Toxicology, 2007, 242 (1-3), 130-143.
49. Stummann, T.C.; Hareng, L.; Bremer, S. Hazard assessment of methylmercury toxicity to neuronal induction in embryogenesis using human embryonic stem cells. Toxicology, 2009, 257 (3), 117-126.
50. Kim, G.D.; Kim, G.J.; Seok, J.H.; Chung, H.M.; Chee, K.M.; Rhee, G.S. Differentiation of endothelial cells derived from mouse embryoid bodies: a possible in vitro vasculogenesis model. Toxicol. Lett., 2008, 180 (3), 166-173.
51. Kim, G.D.; Rhee, G.S.; Chung, H.M.; Chee, K.M.; Kim, G.J. Cytotoxicity of 5-fluorouracil: Effect on endothelial differentiation via cell cycle inhibition in mouse embryonic stem cells. Toxicol. In Vitro, 2009, 23 (4), 719-727.
52. Chaudhary, K.W.; Barrezueta, N.X.; Bauchmann, M.B.; Milici, A.J.; Beckius, G.; Stedman, D.B.; Hambor, J.E.; Blake, W.L.; McNeish, J.D.; Bahinski, A.; Cezar, G.G. Embryonic stem cells in predictive cardiotoxicity: laser capture microscopy enables assay development. Toxicol. Sci., 2006, 90 (1), 149-158.
53. Calabro, A.R.; Konsoula, R.; Barile, F.A. Evaluation of in vitro cytotoxicity and paracellular permeability of intact monolayers with mouse embryonic stem cells. Toxicol. In Vitro, 2008, 22 (5), 1273-1284.
54. Xu, C.; He, J.Q.; Kamp, T.J.; Police, S.; Hao, X.; O'Sullivan, C.; Carpenter, M.K.; Lebkowski, J.; Gold, J.D. Human embryonic stem cell-derived cardiomyocytes can be maintained in defined medium without serum. Stem Cells Dev., 2006, 15 (6), 931-941.
55. Xu, C.; Police, S.; Hassanipour, M.; Gold, J.D. Cardiac bodies: a novel culture method for enrichment of cardiomyocytes derived from human embryonic stem cells. Stem Cells Dev., 2006, 15 (5), 631-639.
56. Adler, S.; Pellizzer, C.; Hareng, L.; Hartung, T.; Bremer, S. First steps in establishing a developmental toxicity test method based on human embryonic stem cells. Toxicol. In Vitro, 2008, 22 (1), 200-211.
57. Mehta, A.; Konala, V.B.; Khanna, A.; Majumdar, A.S. Assessment of drug induced developmental toxicity using human embryonic stem cells. Cell Biol. Int., 2008, 32 (11), 1412-1424.
58. Kim, S.K.; Kim, B.K.; Shim, J.H.; Gil, J.E.; Yoon, Y.D.; Kim, J.H. Nonylphenol and octylphenol-induced apoptosis in human embryonic stem cells is related to Fas-Fas ligand pathway. Toxicol. Sci., 2006, 94 (2), 310-321.
59. George, S.; Heng, B.C.; Vinoth, K.J.; Kishen, A.; Cao, T. Comparison of the response of human embryonic stem cells and their differentiated progenies to oxidative stress. Photomed. Laser Surg., 2009, 27 (4), 669-674.
60. Saretzki, G.; Armstrong, L.; Leake, A.; Lako, M.; von Zglinicki, T. Stress defense in murine embryonic stem cells is superior to that of various differentiated murine cells. Stem Cells, 2004, 22 (6), 962-971.
61. Flora, S.J.; Mehta, A. Monoisoamyl dimercaptosuccinic acid abrogates arsenic-induced developmental toxicity in human embryonic stem cell-derived embryoid bodies: comparison with in vivo studies. Biochem. Pharmacol., 2009, 78 (10), 1340-1349.
62. Cao, T.; Lu, K.; Fu, X.; Heng, B.C. Differentiated fibroblastic progenies of human embryonic stem cells for toxicology screening. Cloning Stem Cells, 2008, 10 (1), 1-10.
63. Hill, E.J.; Woehrling, E.K.; Prince, M.; Coleman, M.D. Differentiating human NT2/D1 neurospheres as a versatile in vitro 3D model system for developmental neurotoxicity testing. Toxicology, 2008, 249 (2-3), 243-250.
64. Hao, Y.; Creson, T.; Zhang, L.; Li, P.; Du, F.; Yuan, P.; Gould, T.D.; Manji, H.K.; Chen, G. Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis. J. Neurosci., 2004, 24 (29), 6590-6599.
65. Hsieh, J.; Gage, F.H. Epigenetic control of neural stem cell fate. Curr. Opin. Genet. Dev., 2004, 14 (5), 461-469.
66. Zeng, X.; Chen, J.; Deng, X.; Liu, Y.; Rao, M.S.; Cadet, J.L.; Freed, W.J. An in vitro model of human dopaminergic neurons derived from embryonic stem cells: MPP+ toxicity and GDNF neuroprotection. Neuropsychopharmacology, 2006, 31 (12), 2708-2715.
67. EPA, C. Proposed identification of environmental tobacco smoke as a toxic air contaminant. Part B: Health Effects; California Environmental Protection Agency, Office of Environmental Health Hazard Assessment: Sacramento, 2005.
68. Benowitz, N.L. Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction. Clin. Pharmacol. Ther., 2008, 83 (4), 531-541.
69. Haustein, K.O. Cigarette smoking, nicotine and pregnancy. Int J Clin Pharmacol. Ther., 1999, 37 (9), 417-427.
70. Stillman, R.J.; Rosenberg, M.J.; Sachs, B.P. Smoking and reproduction. Fertil Sterility, 1986, 46 (4), 545-566.
71. Talbot, P.; Riveles, K. Smoking and reproduction: the oviduct as a target of cigarette smoke. Reprod Biol. Endocrinol., 2005, 3, 52.
72. Shiverick, K.T.; Salafia, C. Cigarette smoking and pregnancy I: ovarian, uterine and placental effects. Placenta, 1999, 20 (4), 265-272.
73. Rogers, J.M. Tobacco and pregnancy: overview of exposures and effects. Birth Defects Res. C Embryo. Today, 2008, 84 (1), 1-15.
74. Talbot, P. In vitro assessment of reproductive toxicity of tobacco smoke and its constituents. Birth Defects Res. C Embryo Today, 2008, 84 (1), 61-72.
75. Mortensen, E.L.; Michaelsen, K.F.; Sanders, S.A.; Reinisch, J.M. A dose-response relationship between maternal smoking during late pregnancy and adult intelligence in male offspring. Paediatr Perinat Epidemiol., 2005, 19 (1), 4-11.
76. Perera, F.P.; Rauh, V.; Whyatt, R.M.; Tsai, W.Y.; Tang, D.; Diaz, D.; Hoepner, L.; Barr, D.; Tu, Y.H.; Camann, D.; Kinney, P. Effect of prenatal exposure to airborne polycyclic aromatic hydrocarbons on neurodevelopment in the first 3 years of life among inner-city children. Environ Health Perspect, 2006, 114 (8), 1287-1292.
77. Rauh, V.A.; Whyatt, R.M.; Garfinkel, R.; Andrews, H.; Hoepner, L.; Reyes, A.; Diaz, D.; Camann, D.; Perera, F.P. Developmental effects of exposure to environmental tobacco smoke and material hardship among inner-city children. Neurotoxicol. Teratol., 2004, 26 (3), 373-385.
78. Knoll, M.; Talbot, P. Cigarette smoke inhibits oocyte cumulus complex pick-up by the oviduct independent of ciliary beat frequency. Reprod., Toxicol., 1998, 12, 57-68.
79. Lin, S.; Tran, V.; Talbot, P. Comparison of toxicity of smoke from traditional and harm reduction cigarettes using embryonic stem cells as a novel model for pre-implantation development. Hum. Reprod., 2009, 24, 386-397.
80. Zdravkovic, T.; Genbacev, O.; LaRocque, N.; McMaster, M.; Fisher, S. Human embryonic stem cells as a model system for studying the effects of smoke exposure on the embryo. Reprod. Toxicol., 2008, 26 (2), 86-93.
81. McCann, M.F.; Irwin, D.E.; Walton, L.A.; Hulka, B.S.; Morton, J.L.; Axelrad, C.M. Nicotine and cotinine in the cervical mucus of smokers, passive smokers, and nonsmokers. Cancer Epidemiol. Biomark. Prev., 1992, 1 (2), 125-129.
82. Zhang, H.; Guo, D.; Wang, L.; Zhao, Y.; Cheng, Y.; Qiao, Z. Effect of nicotine on Oct-4 and Rex-1 expression of mouse embryonic stem cells. Reprod. Toxicol., 2005, 19 (4), 473-478.
83. Greenlee, A.R.; Kronenwetter-Koepel, T.A.; Kaiser, S.J.; Liu, K. Comparison of Matrigel and gelatin substrata for feeder-free culture of undifferentiated mouse embryonic stem cells for toxicity testing. Toxicol. In Vitro, 2005, 19 (3), 389-397.
84. Greenlee, A.R.; Kronenwetter-Koepel, T.A.; Kaiser, S.J.; Ellis, T.M.; Liu, K. Combined effects of Matrigel and growth factors on maintaining undifferentiated murine embryonic stem cells for embryotoxicity testing. Toxicol. In Vitro, 2004, 18 (4), 543-553.
85. Amit, M.; Itskovitz-Eldor, J. Embryonic stem cells: isolation, characterization and culture. Adv. Biochem. Eng. Biotechnol., 2009, 114,173-184.
86. Ludwig, T.; J, A.T. Defined, feeder-independent medium for human embryonic stem cell culture. Curr. Protoc. Stem Cell Biol., 2007, Chap. 1, Unit 1C 2.
87. Prestwich, G.D. Evaluating drug efficacy and toxicology in three dimensions: using synthetic extracellular matrices in drug discovery. Acc Chem. Res., 2008, 41 (1), 139-148.
88. Soderdahl, T.; Kuppers-Munther, B.; Heins, N.; Edsbagge, J.; Bjorquist, P.; Cotgreave, I.; Jernstrom, B. Glutathione transferases in hepatocyte-like cells derived from human embryonic stem cells. Toxicol. In Vitro, 2007, 21 (5), 929-937.
89. Ding, S.; Wu, T.Y.; Brinker, A.; Peters, E.C.; Hur, W.; Gray, N.S.; Schultz, P.G. Synthetic small molecules that control stem cell fate. Proc. Natl. Acad. Sci. USA, 2003, 100 (13), 7632-7637.
90. Cezar, G.G. Can human embryonic stem cells contribute to the discovery of safer and more effective drugs? Curr. Opin. Chem. Biol., 2007, 11 (4), 405-409.
91. MacDonald, M.L.; Lamerdin, J.; Owens, S.; Keon, B.H.; Bilter, G.K.; Shang, Z.; Huang, Z.; Yu, H.; Dias, J.; Minami, T.; Michnick, S.W.; Westwick, J.K. Identifying off-target effects and hidden phenotypes of drugs in human cells. Nat. Chem. Biol., 2006, 2 (6), 329-337.
92. Greaves, P.; Williams, A.; Eve, M. First dose of potential new medicines to humans: how animals help. Nat. Rev. Drug Discov., 2004, 3 (3), 226-236.